3. Assessment

The assessment of disease activity and extent including complications


Full content only available after log-in


3.1.  Understands the appropriate investigations for assessing disease activity and extent including:

  • Inflammatory markers in blood and stool 
  • Upper and lower GI endoscopy / capsule endoscopy / enteroscopy 
  • Imaging techniques, including: CT, MRI, barium imaging and ultrasound

3.2.  Phenotypic classification of CD and UC

3.3.  Understands the circumstances in which disease activity and extent should be reassessed

3.4.  Knowledge of complications and appropriate action in terms of investigation and management


        
 
Topic:




Programme Phase:



Content Format:








Page: () 1 2 3 4

Topic 3.1 :

Serrated lesions in IBD

R. Feakins

ECCO'18 Vienna

Webcast + PPT
 


Topic 3.1; 3.2 :

Cross-sectional imaging

A. Laghi

ECCO'18 Vienna

Webcast + PPT
 


Topic 3.1; 3.3 :

Evolution of disease pathways over time in CD early versus late disease

G. Rogler

ECCO'18 Vienna

Webcast + PPT
 


Topic 3.1; 3.3; 3.4 :

ECCO-ESGAR Guidelines: Present and future of diagnostic techniques for IBD

J. Stoker

ECCO'18 Vienna

Webcast + PPT
 


Topic 3.1; 3.4 :

Patient Reported Outcomes

L. Peyrin-Biroulet

ECCO'18 Vienna

Webcast + PPT
 


Topic 3.12 :

Obesity in IBD

M. Lomer

ECCO'18 Vienna

PPT
 


Topic 3.2 :

What are risk factors for complicated IBD outcome?

K. Gecse

ECCO'18 Vienna

PPT
 


Topic 3.4 :

Dysplasia vs reactive: A practical approach

M. Svrcek

ECCO'18 Vienna

PPT
 


Page: () 1 2 3 4